Brain Training for Substance Use Disorders
Neurotype Inc. · with University of Minnesota, National Institute on Drug Abuse (NIDA) · NCT06870110
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- January 17, 2025
- Record last updated
- March 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game performance and guides game difficulty.
Being studied: Bias Modification Biofeedback
Conditions: Opioid Use Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
OUD patient participants
- Admitted into chemical treatment with opioid use being a reason for treatment;
- DSM-IV-TR diagnosis of OUD;
- Ability to provide informed consent;
- A minimum of a 6th grade reading level; and
- Able and willing to provide own contact information for follow-up visit(s).
Control participants
- Age- and gender-matched to an OUD patient participant in the study;
- Ability to provide informed consent;
- A minimum of a 6th grade reading level;
- Able and willing to provide own contact information for follow-up visit(s).
Exclusion Criteria
OUD patient participants
- Refusal or inability to consent;
- Pregnant;
- History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures not caused by withdrawal from substances, Other [please specify]);
- Inability to see text and photos clearly on the computer display; and
- Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.
Control participants
- Refusal or inability to consent;
- Pregnant;
- History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures, Other [please specify]);
- Inability to see text and photos clearly on the computer display;
- Current or previous problems using opioids, other prescription (prescribed or not prescribed) or illicit drugs;
- Regular nicotine user (e.g., cigarette smoker, e-cig user) within the past 12 months; and
- Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.
Recruiting US locations
University of Minnesota - Department of Psychiatry & Behavioral Health
Minneapolis, MN 55454
Site contact: Scott Burwell, PhD · 612-790-9304 · burwell@umn.edu
Study contacts (from the official record)
- Scott Burwell, PhD · 612-790-9304 · burwell@umn.edu
- Scott Burwell, PhD · 651-421-1696 · scott@neurotype.io
Similar studies in Minnesota
All healthy volunteers studies in Minnesota →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- Location
- Dilworth, MN + 2 other US sites
- Eligibility basics
- Ages 25–75
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75